Il-10 controls th2-type cytokine production and eosinophil infiltration in a mouse model of allergic airway inflammation

Immunobiology

Volumn 216, Issue 7, 2011, Pages 811-820

  Kosaka, Shinichiro ^a   Tamauchi, Hidekazu ^b   Terashima, Masazumi ^c   Maruyama, Hiroko ^a   Habu, Sonoko ^d   Kitasato, Hidero ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Dainippon Sumitomopharma Co   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Asthma; Eosinophils; GATA 3; IL 10; Th2 cytokine

Indexed keywords

ALLERGEN; ALUMINUM POTASSIUM SULFATE; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR GATA 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; EOSINOPHIL COUNT; IMMUNOREGULATION; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; TH2 CELL;

ALLERGENS; ANIMALS; ASTHMA; CELL LINE; CELL MOVEMENT; CYTOKINES; EOSINOPHILS; GATA3 TRANSCRIPTION FACTOR; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OVALBUMIN; PNEUMONIA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TH2 CELLS;

EID: 79957590840     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.12.003     Document Type: Article

References (68)

1. Agematsu K., Nagumo H., Oguchi Y., Nakazawa T., Fukushima K., Yasui K., Ito S., Kobata T., Morimoto C., Komiyama A. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood 1998, 91:173-180.
2. Agematsu K., Hokibara S., Nagumo H., Shinozaki K., Yamada S., Komiyama A. Plasma cell generation from B-lymphocytes via CD27/CD70 interaction. Leuk. Lymphoma 1999, 5:219-225.
3. Akbari O., DeKruyff R.H., Umetsu D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2001, 2:725-731.
4. Akbari O., Freeman G.J., Meyer E.H., Greenfield E.A., Chang T.T., Sharpe A.H., Berry G., DeKruyff R.H., Umetsu D.T. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 2002, 8:1024-1032.
5. Akdis C.A., Blesken T., Akdis M., Wüthrich B., Blaser K. Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. 1998, 102:98-106.
6. Asadullah K., Sterry W., Stephanek K., Jasulaitis D., Leupold M., Audring H., Volk H.D., Döcke W.D. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J. Clin. Invest. 1998, 101:783-794.
7. Asadullah K., Friedrich M., Hanneken S., Rohrbach C., Audring H., Vergopoulos, Merle Ebeling A., Döcke W.D., Volk H.D., Sterry W. Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings. J. Invest. Dermatol. 2001, 116:721-727.
8. Bacharier L.B., Geha R.S. Molecular mechanisms of IgE regulation. J. Allergy Clin. Immunol. 2000, 105:S547-S558.
9. Barbara G., Xing Z., Hogaboam C.M., Gauldie J., Collins S.M. Interleukin 10 gene transfer prevents experimental colitis in rats. Gut 2000, 46:344-349.
10. Bochner B.S., Undem B.J., Lichtenstein L.M. Immunological aspects of allergic asthma. Annu. Rev. Immunol. 1994, 12:295-335.
11. Borish L. Genetics of allergy and asthma. Ann. Allergy Asthma Immunol. 1999, 82:413-424.
12. Buelems C., Willems F., Delvaux A., Piérard G., Delville J.P., Velu T., Goldman M. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur. J. Immunol. 1995, 25:2668-2672.
13. Chernoff A.E., Granowitz E.V., Shapiro L., Vannier E., Lonnemann G., Angel J.B., Kennedy J.S., Rabson A.R., Wolff S.M., Dinarello C.A. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J. Immunol. 1995, 154:5492-5499.
14. Choe J., Choi Y.S. IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells. Eur. J. Immunol. 1998, 28:508-515.
15. Connors M., Giese N.A., Kulkarni A.B., Firestone C.Y., Morse H.C., Murphy B.R. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J. Virol. 1994, 68:5321-5325.
16. Coyle A.J., Tsuyuki S., Bertrand C., Huang S., Aguet M., Alkan S.S., Anderson G.P. Mice lacking the IFN-gamma receptor have impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J. Immunol. 1996, 156:2680-2685.
17. D'Andrea A., Aste-Amezaga M., Valiante N.M., Ma X., Kubin M., Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 1993, 178:1041-1048.
18. Del Prete G., De Carli M., Almerigogna F., Giudizi M.G., Biagiotti R., Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 1993, 150:353-360.
19. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 1991, 174:1209-1220.
20. de Waal Malefyt R., Yssel H., de Vries J.E. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J. Immunol. 1993, 150:4754-4765.
21. Ding L., Linsley P.S., Huang L.Y., Germain R.N., Shevach E.M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 1993, 151:1224-1234.
22. Egan R.W., Athwahl D., Chou C.C., Emtage S., Jehn C.H., Kung T.T., Mauser P.J., Murgolo N.J., Bodmer M.W. Inhibition of pulmonary eosinophilia and hyperreactivity by antibodies to interleukin-5. Int. Arch. Allergy Immunol. 1995, 107:321-322.
23. Finnegan A., Kaplan C.D., Cao Y., Eibel H., Glant T.T., Zhang J. Collagen-induced arthritis is exacerbated in IL-10-deficient mice. Arthritis Res. Ther. 2003, 5:R18-R24.
24. Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989, 170:2081-2095.
25. Fiorentino D.F., Zlotnik A., Vieira P., Mosmann T.R., Howard M., Moore K.W., O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 1991, 146:3444-3451.
26. Foster P.S., Hogan S.P., Ramsay A.J., Matthaei K.I., Young I.G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 1996, 183:195-201.
27. Grpux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., Roncarolo M.G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737-742.
28. Herminajeng E., Sosroseno W., Bird P.S. The Effects of Interleukin-10 Depletion In Vivo on the Immune Response to Porphyromonas gingivalis in a Murine Model. J. Periodontol. 2001, 72:1527-1534.
29. Humbert M., Menz G., Ying S., Corrigan C.J., Robinson D.S., Durham S.R., Kay A.B. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol. Today 1999, 201:528-533.
30. Jeannin P., Delneste Y., Lecoanet-Henchoz S., Gauchat J.F., Ellis J., Bonnefoy J.Y. CD86 (B7-2) on human B cells. A functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells. J. Biol. Chem. 1997, 272:15613-15639.
31. Jonathan M.S. Epidemiology of atopic dermatitis and atopic march in children. Immunol. Allergy Clin. N. Am. 2010, 30:269-280.
32. Jonathan M.S. From atopic dermatitis to asthma: the atopic march. Ann. Allergy Asthma Immunol. 2010, 105:99-106.
33. Kindler V., Zubler R.H. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3. J. Immunol. 1997, 159:2085-2090.
34. Kobayashi N., Nagumo H., Agematsu K. IL-10 enhances B-cell IgE synthesis by promoting differentiation into plasma cells, a process that is inhibited by CD27/CD70 interaction. Clin. Exp. Immunol. 2002, 129:446-452.
35. Lee J.J., McGarry M.P., Farmer S.C., Denzler K.L., Larson K.A., Carrigan P.E., Brenneise I.E., Horton M.A., Haczku A., Gelfand E.W., Leikauf G.D., Lee N.A. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathogenic of asthma. J. Exp. Med. 1997, 185:2143-2156.
36. Lelievre E., Sarrouilhe D., Morel F., Preud'Homme J.L., Wijdenes J., Lecron J.C. Preincubation of human resting T cell clones with interleukin 10 strongly enhances their ability to produce cytokines after stimulation. Cytokine 1998, 10:831-840.
37. Magnan A., van Pee D., Bongrand P., Vervloet D. Alveolar macrophage interleukin (IL)-10 and IL-12 production in atopic asthma. Allergy 1998, 53:1092-1095.
38. Mauser P.J., Pitman A.M., Fernandez X., Zurcher J., Kung T., Jones H., Watnick A.S., Egan R.W., Kreutner W. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am. J. Respir. Crit. Care Med. 1995, 152:467-472.
39. Miller D.G., Miller A.D. A family of retroviruses that utilize related phosphate transporters for cell entry. J. Virol. 1994, 68:8270-8276.
40. Miller A.D. Cell surface receptors for retroviruses and implications for gene transfer. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:11407-11413.
41. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
42. Moore K.W., O'Garra A., de Waal, Malefyt R., Vieira P., Mosmann T.R. Interleukin-10. Annu. Rev. Immunol. 1993, 11:165-190.
43. Möller G.M., Overbeek S.E., Van Helden-Meeuwsen C.G., Van Haarst J.M., Prens E.P., Mulder P.G., Postma D.S., Hoogsteden H.C. Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin. Exp. Allergy 1996, 26:517-524.
44. Murakami Y., Akahoshi T., Kawai S., Inoue M., Kitasato H. Antiinflammatory effect of retrovirally transfected interleukin-10 on monosodium urate monohydrate crystal-induced acute inflammation in murine air pouches. Arthritis Rheum. 2002, 46:2504-2513.
45. Nagumo H., Agematsu K. Synergistic augmentative effect of interleukin-10 and CD27/CD70 interactions on B-cell immunoglobulin synthesis. Immunology 1998, 4:388-394.
46. Nakagome K., Dohi M., Okunishi K., Komagata Y., Nagatani K., Tanaka R., Jun-ichi Miyazaki J., Yamamoto K. In vivo IL-10 gene delivery suppresses airway eosinophilia and hyperreactivity by down-regulating APC functions and migration without impairing the antigen-specific systemic immune response in a mouse model of allergic airway inflammation. J. Immunol. 2005, 174:6955-6966.
47. Ohmori H., Kanda T., Takai T., Hikida M. Induction of antigen-specific IgE response in murine lymphocytes by IL-10. Immunol. Lett. 1995, 47:127-132.
48. Rennick D.M., Fort M.M., Davidson N.J. Studies with IL-10-/- mice: an overview. J. Leukoc. Biol. 1997, 61:389-396.
49. Robinson D.S., Tsicopoulos A., Meng Q., Durham S., Kay A.B., Hamid Q. Increased interleukin-10 messenger RNA expression in atopic allergy and asthma. Am. J. Respir. Cell. Mol. Biol. 1996, 14:113-117.
50. Rousset F., Garcia E., Defrance T., Péronne C., Vezzio N., Hsu D.H., Kastelein R., Moore K.W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:1890-1893.
51. Rousset F., Peyrol S., Garcia E., Vezzio N., Andujar M., Grimaud J.A., Banchereau J. Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4. Int. Immunol. 1995, 7:1243-1253.
52. Rulifson I.C., Spering A.L., Fields P.E., Fitch F.W., Blustone J.A. CD28 costimulation promote production of Th2 cytokine. J. Immunol. 1987, 158:658-665.
53. Sasaki M., Mathis J.M., Jennings M.H., Jordan P., Wang Y., Ando T., Joh T., Alexander J.S. Reversal of experimental colitis disease activity in mice following administration of an adenoviral IL-10 vector. J. Inflamm. 2005, 2:13-22.
54. Schandene L., Alonso-Vega C., Willems F., Gerard C., Delvaux A., Velu T., Devos R., de Boer M., Goldman M. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol. 1994, 152:4368-4374.
55. Steidler L., Hans W., Schotte L., Neirynck S., Obermeier F., Falk W., Fiers W., Remaut E. Treatment of murine colitis by lactococcus lactis secreting interleukin-10. Science 2000, 289:1352-1355.
56. Stein S.H., Hart T.E., Hoffman W.H., Hendrix C.L., Gustke C.J., Watson S.C. Interleukin-10 promotes anti-collagen antibody production in type I diabetic peripheral B lymphocytes. J. Periodontal. Res. 1997, 32:189-195.
57. Taga K., Mostowski H., Tosato G. Human interleukin-10 can directly inhibit T-cell growth. Blood 1993, 81:2964-2971.
58. Takanashi S., Hasegawa Y., Kanehira Y., Yamamoto K., Fujimoto K., Satoh K., Okamura K. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur. Respir. J. 1999, 14:309-314.
59. Tamauchi H., Terashima M., Ito M., Maruyama H., Ikewaki N., Inoue M., Gao X., Hozumi K., Habu S. Evidence of GATA-3-dependent Th2 commitment during the in vivo immune response. Int. Immunol. 2004, 16:179-187.
60. Tillie-Leblond I., Pugin J., Marquette C.H., Lamblin C., Saulnier F., Brichet A., Wallaert B., Tonnel A.B., Gosset P. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am. J. Respir. Crit. Care Med. 1994, 159:487-494.
61. van Deventer S.J., Elson C.O., Fedorak R.N. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology 1997, 113:383-389.
62. van Oosterhout A.J., Bloksma N. Regulatory T-lymphocytes in asthma. Eur. Respir. J. 2005, 26:918-932.
63. van Scott M.R., Justice J.P., Bradfield J.F., Enright E., Sigounas A., Sur S. IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 278:L667-L674.
64. Verma I.M., Weitzman M.D. Gene therapy: twenty-first century medicine. Annu. Rev. Biochem. 2005, 74:711-738.
65. Virchow J.C. Bronchial asthma: extrinsic, intrinsic or mixed?. Wien Med. Wochenschr. 1996, 146:415-418.
66. Webb L.M., Feldman M. Critical role of CD28/B7 costimulation in the development of human Th2 cytokine-producing cell. Blood 1995, 86:3479-3486.
67. Xu Q., Katakura Y., Yamashita M., Fang S., Tamura T., Matsumoto S.E., Aiba Y., Teruya K., Osada K., Nishikawa R., Shirahata S. IL-10 augments antibody production in in vitro immunized lymphocytes by inducing a Th2-type response and B cell maturation. Biosci. Biotechnol. Biochem. 2004, 68:2279-2284.
68. Yang X., Wang S., Fan Y., Han X. IL-10 deficiency prevents IL-5 overproduction and eosinophilic inflammation in a murine model of asthma-like reaction. Eur. J. Immunol. 2000, 30:382-391.